VSTM
Verastem, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.20
+2.76%Margins
Gross margin
86.7%
EBITDA margin
-228.0%
EBIT margin
-182.6%
Net margin
-231.6%
FCF margin
-186.8%
-405.5%
Return on equity
-98.2%
Return on assets
-119.0%
Return on invested capital
0.40x
Asset turnover
-$162.2M
Cash from operations
$1.51
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026